Skip to content
10-K

Annual Report

ANAPTYSBIO, INC ANAB

0001193125-26-088290

← back to feed
Filed
Mar 3, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 28.75M sh
Shares Diluted FY 2025 · Dec 31, 2025 28.76M sh
Shares Diluted FY 2025 · Dec 31, 2024 28.38M sh
Shares Diluted FY 2025 · Dec 31, 2023 26.92M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $68.63M
Stock Repurchased FY 2025 · Dec 31, 2024 $456K
Stock Repurchased FY 2025 · Dec 31, 2023 $50M
Capex FY 2025 · Dec 31, 2025 $87K
Capex FY 2025 · Dec 31, 2024 $358K
Capex FY 2025 · Dec 31, 2023 $807K
Operating Cash Flow FY 2025 · Dec 31, 2025 $19.7M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$135.34M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$120.8M
Cash And Equivalents FY 2025 · Dec 31, 2025 $238.2M
Cash And Equivalents FY 2025 · Dec 31, 2024 $123.08M
Stockholders Equity FY 2025 · Dec 31, 2025 $37.21M
Stockholders Equity FY 2025 · Dec 31, 2024 $70.87M
Stockholders Equity FY 2025 · Dec 31, 2023 $88.1M
Stockholders Equity FY 2025 · Dec 31, 2022 $262.1M
Current Liabilities FY 2025 · Dec 31, 2025 $38.63M
Current Liabilities FY 2025 · Dec 31, 2024 $45.43M
Current Assets FY 2025 · Dec 31, 2025 $350.25M
Current Assets FY 2025 · Dec 31, 2024 $431.88M
Total Assets FY 2025 · Dec 31, 2025 $364.4M
Total Assets FY 2025 · Dec 31, 2024 $483.83M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.46
Eps Diluted FY 2025 · Dec 31, 2024 −$5.12
Eps Diluted FY 2025 · Dec 31, 2023 −$6.08
Eps Basic FY 2025 · Dec 31, 2025 −$0.46
Eps Basic FY 2025 · Dec 31, 2024 −$5.12
Eps Basic FY 2025 · Dec 31, 2023 −$6.08
Sga Expense FY 2025 · Dec 31, 2025 $50.74M
Sga Expense FY 2025 · Dec 31, 2024 $42.39M
Sga Expense FY 2025 · Dec 31, 2023 $41.95M
Operating Income FY 2025 · Dec 31, 2025 $47.9M
Operating Income FY 2025 · Dec 31, 2024 −$114.95M
Operating Income FY 2025 · Dec 31, 2023 −$164.41M
Revenue FY 2025 · Dec 31, 2025 $234.6M
Revenue FY 2025 · Dec 31, 2024 $91.28M
Revenue FY 2025 · Dec 31, 2023 $17.16M